Curo Oncology

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Melanoma3 trials
• Childhood cancers2 trials

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Eikon Therapeutics1 trial
• HUYABIO International, LLC.1 trial

Running trials

• Recruiting

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  NCT06697301· Phase 2/3· Eikon Therapeutics· Source

  Contact: Lenore Dirker

• Active, not recruiting

  A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

  NCT06054555· Phase 3· Amgen· Source

• Active, not recruiting

  Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

  NCT04674683· Phase 3· HUYABIO International, LLC.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Melanoma1 recruiting